Cooley advised Radionetics Oncology on the transaction, and Wilson Sonsini Goodrich & Rosati acted as patent counsel for Radionetics Oncology and advised the company on patent....
Radionetics’ Strategic Agreement with Eli Lilly
Radionetics Oncology’s $52.5 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Radionetics Oncology on IP matters related to the transaction. Radionetics Oncology announced that it has raised $52.5 million in Series...